18–21 May 2026
Europe/Warsaw timezone

Session

Machine learning and data science 1

19 May 2026, 13:45
Room 14

Room 14

Conveners

Machine learning and data science 1

  • Mar Rodriguez-Girondo (Leiden University Medical Center)

Presentation materials

There are no materials yet.

  1. Lukas Burk (Leibniz Institute for Prevention Research and Epidemiology - BIPS)
    19/05/2026, 13:45
    oral presentation

    Background: Post-COVID Condition (PCC) affects a substantial proportion of individuals following SARS-CoV-2 infection, and the mechanisms driving symptom persistence remain an area of active research. Identifying risk factors associated with PCC development is important for targeted prevention strategies and clinical management. Machine learning (ML) models offer powerful tools for prediction...

    Go to contribution page
  2. Fabiola Del Greco M. (Institute of Biomedicine - Eurac research)
    19/05/2026, 14:03
    oral presentation

    Introduction
    Metabolomics measures small molecules (called metabolites) in cells, tissues, biofluids, that represent intermediates and/or end-products of biochemical/cellular processes. As a results, metabolomics has shown to be useful for predicting disease risks or associated biomarkers. Given the large data complexity and size, the Machine learning (ML) approach represents an appropriate...

    Go to contribution page
  3. Soheila Aghlmandi (University of Basel)
    19/05/2026, 14:21
    oral presentation

    Objectives: To evaluate whether machine learning (ML) applied to comprehensive claims data without diagnostic codes can distinguish a high proportion of antibiotic treatment episodes as urinary tract infection (UTI) or non-UTI cases. Such approaches may be valuable for antimicrobial stewardship when diagnosis-linked datasets are unavailable.
    Methods: Outpatient antibiotic prescription claims...

    Go to contribution page
  4. Shizhe Xu (University of Oxford)
    19/05/2026, 14:39
    oral presentation

    Genome-wide association studies (GWAS) often identify genomic regions containing hundreds or thousands of genetic variants with comparable statistical evidence. Extensive linkage disequilibrium (LD) and the sparsity of causal variants obscure association signals, hindering the identification of true causal variants underlying complex traits. Fine-mapping approaches are introduced to...

    Go to contribution page
  5. Annalena Weissert (TU Dortmund University)
    19/05/2026, 14:57
    oral presentation

    Metabolite discovery can provide insights into disease mechanisms and help to identify potential biomarkers that contribute to the development of new treatments. We present a self-supervised deep learning approach for metabolite discovery. Molecular intensity distributions obtained via MALDI-MSI (matrix-assisted laser desorption/ionization mass spectrometry imaging) are compared with...

    Go to contribution page
Building timetable...